Inotiv, Inc. (FRA:BS50)

Market Cap	26.04M
Revenue (ttm)	430.26M
Net Income (ttm)	-67.24M
Shares Out	n/a
EPS (ttm)	-2.22
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	0.7250
Previous Close	0.6900
Day's Range	0.7250 - 0.7400
52-Week Range	0.6400 - 5.8000
Beta	n/a
RSI	42.04
Earnings Date	Dec 3, 2025

About Inotiv

Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally. It operates through two segments, Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The DMS segment manufactures scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the company’s...

• Industry: Commercial Physical and Biological Research
• Founded: 1974
• Employees: 2,075
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: BS50

Financial Performance

In 2024, Inotiv's revenue was $490.74 million, a decrease of -14.27% compared to the previous year's $572.43 million. Losses were -$108.45 million, 3.14% more than in 2023.

Financial numbers in USD